Entering text into the input field will update the search result below

GoodRx faces downgrades, price target cuts following earnings

Mar. 01, 2022 3:10 PM ETGoodRx Holdings, Inc. (GDRX)By: Jonathan Block, SA News Editor4 Comments

Prescription drug bottles in shopping cart on dollar bills

michaelquirk/iStock via Getty Images

Shares of GoodRx (GDRX -38.9%) have continued to fall today after reporting its Q4 2021 results after the closing bell Monday and soft guidance.

As a result, several Street firms have downgraded the stock and/or cut

Recommended For You

Comments (4)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

This is one of the most mispriced stocks in the mkt today. 55-65% Rule and it’s trading at sub 10x revenue?? Nothing I heard on CC swayed me; this is a classic mispriced stock due to Covid drag on typical doctor visits (ex Covid), which DIRECTLY impacts their growth curve—this a “pull backward” story due to Covid, NOT a “pull forward”. Pretty simple if you’re awake🤔
LoveGotham profile picture
@RestaurantGuy2 I'm with you... although it's been hard to average down with conviction here. What are the metrics for "55-65% rule" ?
jojopuppyfish profile picture
These analysts are a trip. They just move the goalpoasts
Illuminati Investments profile picture
Another Cathie Wood special?
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.